Search Results - "Linssen, G. C. M."

Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry by Uijl, A., Veenis, J. F., Brunner-La Rocca, H. P., van Empel, V., Linssen, G. C. M., Asselbergs, F. W., van der Lee, C., Eurlings, L. W. M., Kragten, H., Al-Windy, N. Y. Y., van der Spank, A., Koudstaal, S., Brugts, J. J., Hoes, A. W.

“…Background Clinical management of heart failure with preserved ejection fraction (HFpEF) centres on treating comorbidities and is likely to vary between…”
Get full text

Differences in guideline-recommended heart failure medication between Dutch heart failure clinics: an analysis of the CHECK-HF registry by Linssen, G. C. M., Veenis, J. F., Brunner-La Rocca, H. P., van Pol, P. E. J., Engelen, D. J. M., van Tooren, R. M., Koornstra-Wortel, H. J. J., Hoes, A. W., Brugts, J. J.

“…Background Heart failure (HF) is associated with poor prognosis, high morbidity and mortality. The prognosis can be optimised by guideline adherence, which…”
Get full text

A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure by Linssen, G. C. M., Jaarsma, T., Hillege, H. L., Voors, A. A., van Veldhuisen, D. J.

“…Aims Concentrations of circulating B‑type natriuretic peptides provide important prognostic information in heart failure (HF) patients. We directly compared…”
Get full text

The effects of positive psychology interventions on well-being and distress in patients with cardiovascular diseases: A systematic review and Meta-analysis by Tönis, K.J.M., Kraiss, J.T., Linssen, G.C.M., Bohlmeijer, E.T.

“…Positive psychology interventions (PPIs) have been found to be effective for psychiatric and somatic disorders. However, a systematic review and meta-analysis…”
Get full text

Heart failure treatment in patients with and without obesity with an ejection fraction below 50 by Aga, Yaar S., Radhoe, Sumant P., Aydin, Dilan, Linssen, G. C. M., Rademaker, Philip C., Geerlings, Peter R., van Gent, Marco W. F., Aksoy, Ismail, Oosterom, Liane, Brunner‐La Rocca, Hans‐Peter, van Dalen, Bas M., Brugts, Jasper J.

“…Background The aim of this study was to assess heart failure (HF) treatment in patients with and without obesity in a large contemporary real‐world Western…”
Get full text

A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure: Design and rationale of the MONITOR HF multicentre randomised clinical trial by Brugts, J. J., Veenis, J. F., Radhoe, S. P., Linssen, G. C. M., van Gent, M., Borleffs, C. J. W., van Ramshorst, J., van Pol, P., Tukkie, R., Spee, R. F., Emans, M. E., Kok, W., van Halm, V., Handoko, L., Beeres, S. L. M. A., Post, M. C., Boersma, E., Lenzen, M. J., Manintveld, O. C., Koffijberg, H., van Baal, P., Versteegh, M., Smilde, T. D., van Heerebeek, L., Rienstra, M., Mosterd, A., Delnoy, P. P. H., Asselbergs, F. W., Brunner-La Rocca, H. P., de Boer, R. A.

“…Background Assessing haemodynamic congestion based on filling pressures instead of clinical congestion can be a way to further improve quality of life (QoL)…”
Get full text

TWENTE Study: The Real-World Endeavor Resolute Versus Xience V Drug-Eluting Stent Study in Twente: study design, rationale and objectives by Basalus, M. W. Z., Tandjung, K., van Houwelingen, K. G., Stoel, M. G., de Man, F. H. A. F., Louwerenburg, J. W., Saïd, S. A. M., Linssen, G. C. M., Kleijne, M. A. W. J., van der Palen, J., Huisman, J., Verhorst, P. M. J., von Birgelen, C.

“…Background. New-generation drug-eluting stents (DES) may solve several problems encountered with first-generation DES, but there is a lack of prospective…”
Get full text

Clinical outcome up to 2 years after percutaneous coronary intervention in all-comers with concomitant symptomatic peripheral arterial disease: a pooled analysis in 9,204 randomized trial participants by Pinxterhuis, T H, Ploumen, E H, Zocca, P, Doggen, C J M, Schotborgh, C E, Anthonio, R L, Roguin, A, Danse, P W, Benit, E, Aminian, A, Stoel, M G, Linssen, G C M, Geelkerken, R H, Von Birgelen, C

“…Abstract Background An increasing number of patients with coronary artery disease, who undergo percutaneous coronary intervention, also have symptomatic…”
Get full text

Differences in chronic heart failure treatment between patients with and without obesity in a large real-world heart failure population by Aga, Y, Radhoe, S P, Aydin, D, Linssen, G C M, Moons, A H M, Pronk, A C B, Engelen, D J M, Van Tooren, R M, Brunner-La-Rocca, H P, Dalen, B M, Brugts, J J

“…Abstract Background Obesity is a well-established risk factor for the development of heart failure (HF). Numerous studies have demonstrated that HF patients…”
Get full text

Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study by Henkens, M T H M, Raafs, A G, Verdonschot, J A J, Linschoten, M, van Smeden, M, Wang, P, van der Hooft, B H M, Tieleman, R, Janssen, M L F, Ter Bekke, R M A, Hazebroek, M R, van der Horst, I C C, Asselbergs, F W, Magdelijns, F J H, Heymans, S R B

“…Age and comorbidities increase COVID-19 related in-hospital mortality risk, but the extent by which comorbidities mediate the impact of age remains unknown. In…”
Get full text

P6517Three-year clinical outcome of patients with abnormal glucose metabolism treated with contemporary drug-eluting stents by Ploumen, E H, Buiten, R A, Kok, M M, Zocca, P, Doggen, C J M, Kant, G D, Stoel, M G, De Man, F H A F, Linssen, G C M, Doelman, C, Sattar, N, Von Birgelen, C

“…Abstract Background/Introduction Patients with coronary artery disease that have an abnormal glucose metabolism are known to have more extensive and complex…”
Get full text

Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial by Nguyen, Bao Oanh, Crijns, Harry J G M, Tijssen, Jan G P, Geelhoed, Bastiaan, Hobbelt, Anne H, Hemels, Martin E W, Mol, W J Myke, Weijs, Bob, Alings, Marco, Smit, Marcelle D, Tieleman, Robert G, Tukkie, Raymond, Van Veldhuisen, Dirk J, Van Gelder, Isabelle C, Rienstra, Michiel, Van Gelder, I C, Alings, M, Tieleman, R G, Aksoy, I, Linssen, G C M, Bosker, H A, Verdel, G J E, Cramer, E, Crijns, H J G M, Tuininga, Y S, Van Der Galiën, A, Hagens, V, De Ruiter, G S

“…Abstract Aims The Routine vs. Aggressive risk factor driven upstream rhythm Control for prevention of Early persistent atrial fibrillation (AF) in heart…”
Get full text

Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands: Design and rationale of the by Brugts, J. J., Linssen, G. C. M., Hoes, A. W., Brunner-La Rocca, H. P.

Get full text

Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands: Design and rationale of the Chronic Heart failure ESC guideline-based Cardiology practice Quality project (CHECK-HF) registry by Brugts, J. J., Linssen, G. C. M., Hoes, A. W., Brunner-La Rocca, H. P.

“…Aims Data from patient registries give insight into the management of patients with heart failure (HF), but actual data from unselected real-world HF patients…”
Get full text

Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands by Brugts, J. J, Linssen, G. C. M, Hoes, A. W, Brunner-La Rocca, H. P, van >Amerongen, H, Derks, A, Hering, D, Kruik, H. J, Martherus, M, Pluimers, J, Uitzetter, A, Veldhuis, D, Huisman, N. A. M, van der Spank, A, Winter, J, Moons, A. H. M, Smit, M, Oortman, R. M, Aengenend, N, Koornstra-Wortel, H. J. J, Balhuizen, K. J, Plomp, J, van Drimmelen, A. A. M, Snoek, I, van Anken, A, van Rijn, L, Smeele, F. J. J, van Gent, M. W. F, van Lingen-Koppejan, G. C, Smits, P. A, Trossèl, H. I. S, Schaafsma, H. J, Tuin-v.d. Kolk, G, Vermeulen-v.d. Wetering, H.D, Zimmerman, J, Brakel, J. W, Nagelsmit, M. J, Veenstra, W, Aksoy, I, Meulmeester-Sinke, D. C, Monraats, P. S, Reijnierse-Buitenwerf, H. H, Witkam-Bal, A. H, Boes-van Laar, M, Schoep-Bezemer, H. M. C, Westendorp, P. H. M, van Dieën, A, Viergever, E. P, Vossebelt, E. B, Takens, L. H, de Valk-Bedijn, W. E. H, Hendrick, R, Kragten, J. A, Stoot, N. P, Barandiaran Aizpurua, M. A, Marcks, N. G. H. M, Merken, J, Corsten, L, Kelder, J. C, van Tooren, R. M, Hillebrink, T, Oosterom, L, Telgt, N, van Dalen, B. M, van Miltenburg, A, Slingerland, N, Sonneveld, B, Bird-Lake, E, Hoek-Verschoor, J, van der Ree, A, Erol-Yilmaz, A, den Hartog-Taai, L, Middelburg-Poldervaart, P, Rademaker, P. C, de Smet, S, de Theije, E. G. M. V, de Wit, T. J, Langerveld, J, Morang-van Drempt, C. J, Vermeulen, M. M, Foolen, Y, Pronk, A. C. B, Valk, L. K, Grosfeld, M. J. W, Aertsen, M, Engelen, D. J. M, Kneijber, V, van Santvoord, J, Eurlings, L. W. M, Hazeleger, R, Koopman-Verhagen, A. M, Maessen, G, Pansters, C. W. A. M, Geerlings, P. R, de Boer, M, Kolkman, A, van der Lee, C, Blonk, R, Krijger, J, Smits, J. P. P

“…AimsData from patient registries give insight into the management of patients with heart failure (HF), but actual data from unselected real-world HF patients…”
Get full text

Clinical impact of off-label use of contemporary drug-eluting stents in the randomized TWENTE trial by Sen, H., Tandjung, K., Lam, M. K., Van Houwelingen, K. G., Stoel, M., Louwerenburg, J. W., De Man, F. H. A. F., Linssen, G. C. M., Nienhuis, M. B., Von Birgelen, C.

Get full text

Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting Xience V stents: two-year clinical outcome in the gender-stratified randomized, controlled TWENTE trial by Tandjung, K., Sen, H., Lam, M. K., Stoel, M. G., De Man, F. H. A. F., Louwerenburg, J. W., Linssen, G. C. M., Nijhuis, R., Nienhuis, M. B., Von Birgelen, C.

Get full text

A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure by Brugts, J. J, Veenis, J. F, Radhoe, S. P, Linssen, G. C. M, van Gent, M, Borleffs, C. J. W, van Ramshorst, J, van Pol, P, Tukkie, R, Spee, R. F, Emans, M. E, Kok, W, van Halm, V, Handoko, L, Beeres, S. L. M. A, Post, M. C, Boersma, E, Lenzen, M. J, Manintveld, O. C, Koffijberg, H, van Baal, P, Versteegh, M, Smilde, T. D, van Heerebeek, L, Rienstra, M, Mosterd, A, Delnoy, P. P. H, Asselbergs, F. W, Brunner-La Rocca, H. P, de Boer, R. A

“…BackgroundAssessing haemodynamic congestion based on filling pressures instead of clinical congestion can be a way to further improve quality of life (QoL) and…”
Get full text

Fatty acid oxidation capacity and fatty acid-binding protein content of different cell types isolated from rat heart by Linssen, M C, Vork, M M, de Jong, Y F, Glatz, J F, van der Vusse, G J

“…Heart tissue contains appreciable amounts of fatty acid-binding protein (FABP). FABP is thought to play a crucial role in the transport of fatty acids from the…”
Get full text

Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure by Smilde, T D J, Linssen, G C M, Gallemann, D, Kuhn, T, Machnig, T, Mol, P G M, Hillege, H L, Van Wijk, L M, Van Dijk, R B, Van Veldhuisen, D J

“…Chronic heart failure (CHF) is a potential indication for the administration of EMD 87 580, a selective Na+/H+ exchange inhibitor. CHF is often accompanied by…”
Get full text